DIAGNOSTIC RADIOIMMUNOASSAY FOR QUANTI

Acid Phosphatase (prostatic), Tartrate Inhibited

NUCLEAR MEDICAL LABORATORIES, INC.

The following data is part of a premarket notification filed by Nuclear Medical Laboratories, Inc. with the FDA for Diagnostic Radioimmunoassay For Quanti.

Pre-market Notification Details

Device IDK822298
510k NumberK822298
Device Name:DIAGNOSTIC RADIOIMMUNOASSAY FOR QUANTI
ClassificationAcid Phosphatase (prostatic), Tartrate Inhibited
Applicant NUCLEAR MEDICAL LABORATORIES, INC. 803 N. Front St. Suite 3 Mchenry,  IL  60050
Product CodeJFH  
CFR Regulation Number862.1020 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1982-08-03
Decision Date1982-09-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.